– Petosemtamab 1500 mg monotherapy phase 2 interim data continues to demonstrate clinically meaningful activity in 2L+ HNSCC – Conference…
RIYADH, Saudi Arabia, Nov. 20, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research Centre (KFSHRC) in Madinah has…
ISTANBUL, Nov. 8, 2024 /PRNewswire/ -- ZTE Corporation, a global leading provider of integrated information and communication technology solutions, announced…
ISTANBUL, Nov. 8, 2024 /PRNewswire/ -- ZTE Corporation, a global leading provider of integrated information and communication technology solutions, announced…
ISTANBUL, Nov. 8, 2024 /PRNewswire/ -- ZTE Corporation, a global leading provider of integrated information and communication technology solutions, announced…
ISTANBUL, Nov. 8, 2024 /PRNewswire/ -- ZTE Corporation, a global leading provider of integrated information and communication technology solutions, announced…
ISTANBUL, Nov. 8, 2024 /PRNewswire/ -- ZTE Corporation (0763.HK / 000063.SZ), a global leading provider of integrated information and communication…